Jun Guo

发表

Recent progress in targeted therapy for non-small cell lung cancer

Yajun Lin, Xin Zhang, Pu Liu, 2023, Frontiers in Pharmacology.

Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies

Shuangxiu Wu, Zhenxiang Li, Chenyue Zhang, 2022, Cancer science.

Biomarkers of aging

Jiawei Han, Haoteng Yan, Q. Kong, 2023, Science China Life Sciences.

Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population

Xiao Han, Zhehai Wang, Minglei Wang, 2023, Frontiers in Oncology.

Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center

Yulan Sun, W. Jing, Yan Zhang, 2023, Discover Oncology.

Biomarkers of aging

Jiawei Han, Haoteng Yan, Q. Kong, 2023, Science China Life Sciences.

Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer

L. Kong, Dawei Chen, Xinyu Song, 2018 .

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

Zhehai Wang, Huan Shi, Changzheng Li, 2015 .